TNDM earnings
Tandem Diabetes (TNDM) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
- TNDM reports next on Feb 18, 2027, with EPS of 0.08 expected.
- TNDM beat EPS estimates in 10 of its last 17 reports.
TNDM earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Nov 5, 2026 | -0.10 | -0.25 | 59.24% | $283.69M |
| Q2 2026 | Aug 6, 2026 | -0.31 | -0.32 | 3.35% | $254.56M |
| Q1 2026 | May 7, 2026 | -0.30 | -0.46 | 34.78% | $247.22M |
| Q4 2025 | Feb 19, 2026 | -0.01 | -0.05 | 80.00% | $290.38M |
| Q3 2025 | Nov 6, 2025 | -0.31 | -0.31 | 0.00% | $249.25M |
| Q2 2025 | Aug 6, 2025 | -0.48 | -0.40 | -20.00% | $240.68M |
| Q1 2025 | Apr 30, 2025 | -0.67 | -0.60 | -11.67% | $234.42M |
| Q4 2024 | Feb 26, 2025 | 0.01 | -0.23 | 104.35% | $282.65M |
| Q3 2024 | Nov 6, 2024 | -0.35 | -0.40 | 12.50% | $243.97M |
| Q2 2024 | Aug 1, 2024 | -0.48 | -0.54 | 11.11% | $221.91M |
| Q1 2024 | May 2, 2024 | -0.63 | -0.76 | 17.11% | $191.67M |
| Q4 2023 | Feb 21, 2024 | -0.27 | -0.25 | -8.00% | $196.80M |
| Q3 2023 | Nov 1, 2023 | -0.38 | -0.34 | -11.76% | $185.62M |
| Q2 2023 | Aug 3, 2023 | -0.55 | -0.54 | -1.85% | $195.92M |
| Q1 2023 | May 3, 2023 | -1.92 | -0.56 | -242.86% | $169.38M |
| Q4 2022 | Feb 22, 2023 | -0.01 | -0.02 | 50.00% | $220.50M |
| Q3 2022 | Nov 2, 2022 | -0.76 | -0.05 | -1420.00% | $204.55M |